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Introduction
Nowadays nanomaterials within the size of 1–100 nm 
in at least one dimension with the novel, size-related 
properties have attracted the attention of many 
researchers in the area of chemistry, physics, material 
sciences, medicine, microbiology, and biotechnology 
(Rai et al. 2009, 2015; Tran et al. 2013). Silver nano-
particles (AgNPs) are one of the most commonly used 
engineered nanoproducts known for their antimicro-
bial activity (Kim et al. 2007; Rai et al. 2009; Martinez- 
Gutierrez et al. 2010). The progress in research led to the 
inclusion of nanoparticles as biocides in a large number 
of consumer products: chemicals, cosmetics, clothing, 
water filters, and medical devices (Kokura et al. 2010; 
Metak and Ajaal 2013; Zarschler et al. 2016). The appli-
cation of AgNPs as a contrast agent for mammography 
and micro-computed tomography for the ear imaging 
is based on their electric properties (Anil Kumar et al. 
2007; Zou et al. 2015; Zhang et al. 2016b; Lee and Jun 
2019). Despite their widespread use, the biocidal activ-
ity of AgNPs is not fully understood and the prevalence 
of either positive or negative effects on humans and the 
environment are discussed (Bartłomiejczyk et al. 2013; 
Flores-López et al. 2019).
The nature and the level of AgNPs’ molecular cyto-
toxicity are related to various factors: size, composition, 
surface area, charge, red-ox potential, and concentra-
tion (McShan et al. 2014; Riaz et al. 2017). In general, 
AgNPs at the concentrations lower than 25–30 ppm 
do not exhibit toxicity for mammalian cells (Milic et al. 
2015; Zhang et al. 2016a). However, some cytostatic and 
anti-cancer activity is reported at these concentrations 
(AshaRani et al. 2009). Antibacterial activity of AgNPs 
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A b s t r a c t
The progress of research on silver nanoparticles (AgNPs) has led to their inclusion in many consumer products (chemicals, cosmetics, 
clothing, water filters, and medical devices) as a biocide. Despite the widespread use of AgNPs, their biocidal activity is not yet fully under-
stood and is usually associated with various factors (size, composition, surface, red-ox potential, and concentration) and, obviously, specific 
features of microorganisms. There are merely a few studies concerning the interaction of molds with AgNPs. Therefore, the determination 
of the minimal AgNPs concentration required for effective growth suppression of five fungal species (Paecilomyces variotii, Penicillium 
pinophilum, Chaetomium globosum, Trichoderma virens, and Aspergillus brasiliensis), involved in the deterioration of construction materials, 
was particularly important. Inhibition of bacteria (Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli) and yeasts (Can-
dida albicans and Yarrowia lipolytica) was also assessed as the control of AgNPs effectiveness. AgNPs at the concentrations of 9–10.7 ppm 
displayed high inhibitory activity against moulds, yeast, and bacteria. The TEM images revealed that 20 nm AgNPs migrated into bacterial, 
yeast, and fungal cells but aggregated in larger particles (50–100 nm) exclusively inside eukaryotic cells. The aggregation of 20 nm AgNPs 
and particularly their accumulation in the cell wall, observed for A. brasiliensis cells, are described here for the first time.
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is rather well documented in the literature, mainly 
against the following species: Staphylococcus aureus, 
Bacillus subtilis, Pseudomonas aeruginosa, and Escheri-
chia coli (Yoon et al. 2007; Li et al. 2010; Guzman et al. 
2012, Kanawaria et al. 2018). Some information con-
cerning growth inhibition of other bacteria (Enterococ-
cus spp.) and yeast (Candida albicans) by nanosilver is 
also available (Kim et al. 2007; Roe et al. 2008; Lara et al. 
2015). However, the studies of AgNPs interaction with 
cell structures of bacteria and yeasts are scarce. Only 
in few reports the location of AgNPs inside C. albicans 
cells was demonstrated under transmission electron 
microscopy (TEM) or scanning electron microscopy 
(SEM) (Kim et al. 2009; Radhakrishnan et al. 2018).
In opposite to bacteria and yeasts, the research on the 
interactions of AgNPs with filamentous fungi (molds) 
is still evolving (Kanawaria et al. 2018). The results on 
AgNPs’ effects on fungal growth already reported con-
cern mainly dermatophytes and phyto pathogens (Jo 
et al. 2009; Pulit et al. 2013; Xu et al. 2013), not the molds 
found in houses or the air. Studies of AgNPs interaction 
with species involved in biodeterioration of buildings 
and construction materials are scarce. The degradation 
of house construction materials could be observed as the 
action of moulds from Aspergillus, Penicillium, Paecilo-
myces, Trichoderma, and Chaetomium genera (Łukaszuk 
et al. 2011; Kobiałka et al. 2019). Species of those genera 
are commonly used in the normalized test of resistance 
to microbial corrosion of construction material compo-
nents (PN-EN ISO 846, 2002).
The aim of the study was to determine the minimal 
AgNPs concentrations required for effective growth 
inhibition of the selected fungal species (possibly 
occurring as biodeterioration agents) and two uncon-
ventional yeast species (Yarrowia lipolytica and C. albi-
cans). The selected bacterial species: S. aureus, E. coli, 
and P. aeruginosa that may cause human infections were 
used to control the effectiveness of the AgNPs tested. 
The analysis of microbial growth was performed in 
the microbiological analyzer Bioscreen C (Automated 
Growth Curve Analysis System, Lab systems, Finland) 
what allowed for a precise determination (for each spe-
cies) the inhibitory concentration of AgNPs. TEM was 
used to localize the AgNPs inside microbial cells and to 
visualize their aggregation in eukaryotic cells and par-
ticular accumulation in the cell wall of A. brasiliensis.
Experimental
Materials and Methods
Nanoparticles. AgNPs have been synthesized by 
the TK Nano according to the procedure described 
by Koźlecki et al. (2011). The final concentration of 
nanoparticles was 107.2 ± 0.8 mg/l. Nanoparticles were 
characterized by dynamic light scattering (DLS) and 
TEM. The DLS measurements were performed using 
a Photocor Complex apparatus (Photocor Instruments), 
equipped with a 28 mW (657 nm) laser and 288-chan-
nel autocorrelator, operating in multi-tau mode. The 
measurements were carried out in 14.8 mm ID round 
cells, submerged in analytical grade decalin (Fisher 
Scientific), as an index-matching liquid; the scattering 
angle was set at 110°, and the temperature of measure-
ments was fixed at 298 ± 0.05°K. The data analysis was 
performed with DynaLS ver. 2.8.3 software (Alango 
Ltd.), using a method similar to the CONTIN algo-
rithm, but more aggressive concerning the noise (Song 
et al. 2011; Echegoyen and Nerin 2013; Wen et al. 2016).
The imaging with TEM was carried out with a Zeiss 
EM900 microscope (Carl Zeiss AG). Samples were 
dipped on a 300-nickel mesh, coated with Formvar 
(SPI Supplies), and then dried thoroughly. Microphoto-
graphs were recorded on photographic film and then 
scanned using a flatbed scanner with 800 × 800 DPI 
resolution (Hewlett-Packard). The images were pro-
cessed using ImageJ ver. 1.50i software (Pal et al. 2007; 
Bundschunh et al. 2016; Koziróg et al. 2016).
Microorganisms. Microorganisms used in the 
study were obtained from the Deutsche Sammlung 
von Microorganismen und Zellkulturen (DSMZ), and 
the Microorganisms Collection of the Department 
of Biotechnology and Food Microbiology (KBiMŻ) at 
Wrocław University of Environmental and Life Sciences 
(Aspergillus brasiliensis DSMZ1988, Penicillium pino-
philum DSMZ1944, Paecilomyces variotii DSMZ1961, 
Trichoderma virens DSMZ1963, Chaetomium globo-
sum DSMZ1962, Candida albicans DSMZ1386, Yar-
rowia lipolytica KBiMŻ A101, Escherichia coli KBiMŻ, 
Pseudomonas aeruginosa DSMZ939, and Staphylococcus 
aureus subsp. aureus DSMZ799).
Petri dishes assay: the plate agar tests on solid 
medium. Filamentous fungi were cultivated on the sur-
face of a medium composed of 30 g glucose, 2 g NaNO3, 
0.7 g KH2PO4, 0.3 g K2HPO4, 0.5 g KCl, 0.5 g MgSO4 × 
× 7H2O, 0.01 g MnSO4 × 7H2O, and 2g agar per 1 l of 
distilled water. The pH was set to 6.0–6.5 before auto-
claving. AgNPs were added directly into Petri dishes 
before pouring sterilized medium in the following 
volumes of the stock suspension (107 mg/l = 107 ppm): 
0, 0.5, 1 and 5 ml, corresponding to 0 or 2.14, 4.28, and 
21.4 mg of AgNPs. On the solidified media, 0.05 ml of 
the suspension of fungal spores at the concentration 
of 105 CFU/ml was applied to the center of Petri dishes. 
After incubation for 192 h at 25°C, the diameters of the 
developed fungal colonies were measured and com-
pared to those observed in medium without AgNPs. 
The analyses were performed in triplicate for each spe-
cies of filamentous fungi.
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Bioscreen C: the bioassay in liquid media. Biologi-
cal activity of silver nanoparticles in liquid media was 
tested on the three groups of microorganisms (bacteria, 
yeasts, and filamentous fungi). The bacterial cultures 
were carried out in a liquid broth consisting of 15 g of 
dry bullion (Biocorp) and 10 g of glucose dissolved in 
1 liter of distilled water. Cultures of yeast and fungi were 
performed in YPG medium composed of 10 g yeast 
extract, 10 g bacteriological peptone, and 10 g glucose 
per 1 liter of distilled water. The tests were performed in 
the automated Bioscreen C system (Automated Growth 
Curve Analysis System, Lab systems, Finland). The cul-
ture volume in the wells of the Bioscreen C was 300 µl, 
which comprised 250 µl of culture medium, 20 µl of cell 
suspension (final concentration 108 CFU/ml) and 30 µl 
of the AgNP stock suspension to the final concentration 
of 10.7 mg/l. The temperature was maintained at 28°C, 
and the optical density (OD) of the cell suspensions was 
measured automatically at 560–600 nm at regular inter-
vals of 30 min during 72–96 hours of cultivation under 
constant agitation. Each culture variant was performed 
in 5–10 replications.
The data obtained were analyzed using the spread-
sheet software (Microsoft Excel 97) and mean values 
were calculated from replicates for each cultured micro-
organism. The overall standard deviation did not exceed 
15% (Robak 2007). The mean values were used for plot - 
ting growth curves for each strain studied, as the func-
tion of the incubation time and OD of the culture. The 
resultant growth curves were compared to control media.
After the Bioscreen C measurements, the cultures 
were collected and 1 ml of each sample transferred 
to 2 ml Eppendorf tubes, centrifuged for 10 min at 
2000 × g, using a Spectrafuge Mini Centrifuge (Labnet 
International), then 0.7 ml of supernatant was placed on 
a Costar Spin-X 0.2 μm filter with polyamide membrane 
(Corning Inc.), and centrifuged again at 2000 × g for 
10 min to remove the residual cell debris. The permeate 
(0.5 ml) was diluted with 1 ml of deionized water and 
measured using a DLS instrument as described above.
TEM observations of microorganisms and AgNPs. 
Biological material obtained after removal of the resid-
ual medium by centrifugation for 10 min at 2000 × g 
was fixed with 2.5% glutaraldehyde and buffered with 
0.1 M cacodylate buffer overnight at 4°C. Subsequently, 
the material was washed three times in 0.1 M caco-
dylate buffer, followed by post-fixation in 2% osmium 
tetroxide/1.5% potassium ferricyanide in 0.1 M caco-
dylate buffer for 1 h at 4°C. Afterward, the material 
was washed three times with buffer and two times with 
ultrapure water by centrifugation at 600 × g for 5 min. 
Subsequently, the material was incubated with 1% ura-
nyl acetate in ultrapure water overnight at 4°C. Then, 
the samples were washed three times with ultrapure 
water and dehydrated using a graded ethanol series 
(from 30% to 99.9%), followed by infiltration with Epon 
812 resin (by replacing the pure ethanol with 1:1 etha-
nol to resin ratio for 2 h, followed by pure resin). Sample 
blocks were polymerized for 24 h at 60°C. Ultrathin sec-
tions were prepared using an ultramicrotome and glass 
knife (Leica EM UC7). The preparations were observed 
using a field-emission scanning electron microscope 
(FE-SEM, Auriga60, Zeiss) employing a STEM detector, 
at 20 kV acceleration voltages.
Results and discussion
Characterization of nanoparticles. The AgNPs 
were obtained at the concentration of 107.2 mg/l as 
electrostatically stabilized monodispersed spherical 
structures (Fig. 1A). The average nanoparticle diameter, 
Fig. 1. Nanoparticles’ shape (A) and dimensions (B).
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as determined with the dynamic light scattering (DLS) 
analysis, was 20 nm (Fig. 1B).
Microbiological analysis. The biocidal activity of 
AgNPs towards five species of filamentous fungi, two 
yeasts, and two bacterial species was evaluated. Two 
types of microbial growth analyses were performed: 
the cultivation on solid agar medium (Petri dishes) 
and in liquid media (Bioscreen C). The former type of 
growth is suitable for observation of the size of fungal 
colonies and the latter allows for the determination of 
the density of cells and hyphae during micro-batch cul-
tures in Bioscreen C, measured every 30 minutes as an 
optical density (OD).
Evaluation of filamentous fungal growth on solid 
agar medium. Inhibition of fungal growth by AgNPs 
was observed for each of five tested species, however, to 
a different extent (Table I). The growth of P. variotii was 
completely inhibited by 4.28 mg/l of AgNPs (4.28 ppm). 
This concentration of nanosilver in the medium had 
a  lower inhibitory effect on the growth of T. virens 
(66%), P. pinophilum (55%), C. globosum (39%), and 
A. brasiliensis (17%). More pronounced inhibition of 
growth of the last four species was noted for the highest 
tested concentration of AgNPs (21.4 mg/l). The growth 
was completely suppressed for P. pinophilum and C. glo-
bosum, and significantly impaired for A. brasiliensis and 
T. virens (by 96% and 90%, respectively). Pulit et al. 
(2013) reported a 75 – 90% inhibition of the growth of 
Aspergillus niger and Cladosporium cladosporioides with 
a higher concentration of AgNPs (50 mg/l).
This difference in the biocidal effect could be asso-
ciated with the size of nanoparticles. Pulit et al. (2013) 
tested AgNPs particles of 60 nm in diameter, in contrast 
to 20 nm particles analyzed in our study. It has been 
well documented that smaller nanoparticles (< 10 nm) 
exhibit more pronounced anti-proliferative activity 
than larger particles. Nowicka-Krawczyk et al. (2017) 
demonstrated inhibition of algae by AgNPs of 3 nm 
in diameter. In turn, Park et al. (2011) compared the 
effects of AgNPs of 20, 80, and 113 nm in diameter on 
two mouse cell lines (RAW 264.7 and L929) to conclude 
more pronounced cytotoxicity for smaller nanoparti-
cles. Higher antimicrobial activity of small nanoparti-
cles was also reported by Duran et al. (2016).
Evaluation of microbial growth in Bioscreen C. 
As reported by Żarowska et al. (2015), the lowest 
AgNP concentration to cease the growth of bacteria 
(S. aureus, E. coli, and Pseudomonas fluorescens) and 
yeast species (C. albicans, Y. lipolytica, and Saccharo-
myces cerevisiae) was found to be nearly 9 mg/l. Here, 
for Bioscreen C culture evaluation of bacterial, yeast, 
and fungal growth, the AgNPs in the concentration of 
10.7 mg/l were applied and their antimicrobial activ-
ity was confirmed. As expected, the growth of bacteria 
S. aureus, P. aeruginosa, E. coli, and yeast Y. lipolytica 
was completely inhibited (Fig. 2A, 2B).
This followed the results reported in the literature 
where the AgNPs biocidal effects were observed. Sondi 
and Salopek-Sondi (2004) reported 70% inhibition of 
E. coli growth by AgNPs in the concentration of 10 mg/l 
and total inhibition at 50–60 mg/l. Dar et al. (2013) 
found that AgNPs of an average size of 30–70 nm dis-
played inhibition of bacterial growth at a concentra-
tion ten times lower (5 mg/l). Concerning filamentous 
fungi, AgNPs at the concentration of 10.7 mg/l seriously 
influenced and retarded the development of the fol-
lowing species: P. variotii, C. globosum, A. brasiliensis, 
P. pinophilum, and T. virens (Table II). As compared to 
the culture of mixed spores (of five species), the lag 
phase duration increased from 1.5 to nearly 10 times, 
and the final cell density (OD) decreased more than 
36-fold showing serious growth inhibition. The inten-
sity of C. albicans growth fluctuated during the time of 
analysis, in a period of approximately 10 hours (Fig. 2B, 
violet line). This fluctuation is difficult to explain but 
appears to be connected with the presence of AgNPs, 
which probably influences cell metabolism and the 
duplication time. According to Radhakrishnan et al. 
(2018) C. albicans cells treated with AgNPs exhibited 
Growth [%]
Aspergillus brasiliensis 100 100 83.1 3.74
Trichoderma virens 100 100 33.9 9.72
Paecilomyces variotii 100 100  0 0
Penicillium pinophilum 100  57.3 44.8 0
Chaetomium globosum 100  63.9 61.2 0
Table I
AgNP inhibition of the filamentous fungi growth.
Fungal species
AgNPs in the medium [mg/l]
0 21.44.282.14
SM: spores mix (control) 10 1.592 100 36
SM: spores mix +AgNPs 20 1.308 82  5.8
A. brasiliensis +AgNPs 40 1.600 100  8.1
P. pinophilum +AgNPs 30 1.517 95  9.2
P. variotii +AgNPs ~ 68 0.633 40  3.7
T. virens +AgNPs 18 1.306 82  6.5
C. globosum +AgNPs 48 1.063 67  5.2
C. albicans +AgNPs 15 0.953 –  3.8
Y. lipolytica +AgNPs > 96 0.194 –  0
Table II
Lag phase duration and final OD after 96 hours of filamentous 
fungal and yeast growth in BioscreenC without or with AgNPs.
Filamentous fungi
and yeast species
Lag 
phase
[h]
OD
at 96 h
compared to
SM
[%]
initial
[× folds]
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altered surface morphology and cellular ultrastructure, 
membrane fluidity, as well as ergosterol and fatty acids 
content. It was noted that the AgNP-mediated inhibi-
tion by was not only induced by ROS (reactive oxygen 
species) formation. The action of AgNPs on C. albicans 
was also size-dependent. According to Kim et al. (2009), 
AgNPs of 5 nm diameter and at the concentration of 
2 mg/l effectively killed C. albicans yeasts. A compara-
ble concentration (2.5 mg/l) of AgNPs was sufficient 
for the inhibition of Aureobasidium pullulans, and ten 
times higher concentration was needed for the A. niger 
growth inhibition (Żarowska et al. 2015). Therefore, the 
activity of AgNPs against yeasts and filamentous fungi 
requires further studies.
Fig. 2. Microorganism growth in BioscreenC with and without AgNPs: (A) Bacteria: S.a, Staphylococcus aureus; P.a, Pseudomonas aeru-
ginosa; E.c, Escherichia coli; (B) yeasts Y.l, Yarrowia lipolytica, and fungi: Smix, the mixture of spores of five species of filamentous fungi; 
A.b, Aspergillus brasiliensis; P.p, Penicillium pinophilum; P.v, Paecilomyces variotii; T.v, Trichoderma virens,
and Ch.g, Chaetomium globosum.
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Also, difficult to explain is the recovery of growth 
after 20–48 hours of the lag phase (Table II) by four spe-
cies of filamentous fungi, except P. variotii. The recovery 
of cell growth could result from at least two factors. One 
of them could be the microorganism’s ability to syn-
thesize and extracellularly secrete nanoparticles. This 
phenomenon was supported by the results of Dar et al. 
(2013) who proved that AgNPs could be synthesized 
by Cryphonectria spp. from silver nitrate and extracel-
lularly secreted. Also, other mold species can synthesize 
and secrete AgNPs (Tran et al. 2013, Akter et al. 2018). 
Even autoclaved (inactivated) biomass of Aspergillus 
aculeatus was able to synthesize silver nanoparticles 
(Salvadori et al. 2014).
The second factor could be connected to the known 
fungal resistance to metals, including silver (Abou-
Shanab et al. 2007). The resistance to metal as well as 
the nanoparticle biosynthesis could result from the 
activity of the same enzyme, nitrate reductase (EC 
1.7.99.4). Shahverdi et al. (2007) identified nitroreduc-
tase as being responsible for the reduction of AgNO3 to 
AgNPs by Klebsiella pneumoniae, and Anil Kumar et al. 
(2007) described the green synthesis of AgNPs by this 
enzyme isolated from Fusarium oxysporum.
TEM analysis. The observations under TEM 
revealed the sites of AgNPs interaction with cells and 
filaments after nearly four days of the exposition. Nano-
particles accumulated in the cell wall without any aggre-
gation, which was especially visible for A. brasiliensis 
(Fig. 3), and with aggregation in the cells of P. variotii 
and P. pinophilum. The TEM analysis was performed on 
microbial biomass collected after 92 h of culture with 
AgNPs added to the medium. Hence, at the time of 
microscopic observations, the fungal cells had already 
been adapted to the biocide (as shown in Fig. 2), and the 
observed accumulation of AgNPs was probably a result 
of its expulsion from the cells as in A. brasiliensis. This 
particular AgNPs deposition site could be due to their 
association with proteins present on the outer side of the 
cell membrane or with membrane lipids. The protein 
corona formation on AgNPs has been described else-
where (Rahman et al. 2013; del Pino et al. 2014; Bargheer 
et al. 2015); however, the AgNPs deposition between the 
cell wall and cytoplasmic membrane could also involve 
Fig. 3. TEM images of Aspergillus brasiliensis after the growth in the BioscreenC: (a) without AgNPs; (b) with AgNPs visible inside
the cell (black points); (c, d) accumulated within the cell wall.
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the binding of nanoparticles to fatty acids present as 
phospholipids. Recently, Radhakrishman et al. (2018) 
reported an altered profile of fatty acids in the C. albi-
cans cells exposed to AgNPs. However, in our study, no 
such abundant AgNPs deposition was denoted in any 
species studied, and possibly a particular cell wall com-
pound of A. brasiliensis could be involved. In A. fumiga-
tus the major component of the cell wall (30%) is the 
branched β-1,3 and β-1,6 glucans linked to chitin (Latge 
et al. 2005). The β-1,3 and β-1,6 glucans are not present 
in yeast and bacteria. So, these glucans could be involved 
in AgNPs localization in cell wall of A. brasiliensis also. 
It is noteworthy that for P. variotii and P. pinophilum no 
such type of nanoparticle accumulation was observed.
Here, besides their accumulation in cell walls, 
AgNPs were also found inside fungal and bacterial cells, 
especially in the cytoplasm, and outside of destroyed 
cells of P. aeruginosa (Fig. 4 and 5). Morones et al. 
(2005) have already presented similar images of AgNPs 
located outside P. aeruginosa cells.
According to many reports, the activity of AgNPs 
against the cell may involve generation of reactive oxy-
gen species (ROS), damage of macromolecules (DNA, 
proteins), and perforation of membranes due to desta-
bilized conformation of their components, especially 
proteins, lipids, and glycans (Bartłomiejczyk et al. 2013; 
Duran et al. 2016). It appears that the observed damage 
was exerted by the release of Ag+ from nanostructures 
(Duran et al. 2016). The mechanism of interaction of 
silver with the cell is best described for Gram-negative 
bacteria, notably E. coli (Kędziora et al. 2016). AgNPs 
uptake by the cell involves special membrane transport-
ers, proteins of P-type ATPases (Li et al. 1997). Those 
P-type ATP-ases are responsible for the import of inor-
ganic cations to the cytoplasm and the export of these 
ions outside the cytoplasm (Chong et al. 2012). Accord-
ing to Galván Márquez et al. (2018) the decreased 
transcription, reduced endocytosis, and dysfunctional 
electron transport system were observed in S. cerevisiae 
cells exposed to AgNPs.
The TEM analysis (based on the careful inspection 
of 300 images) allowed for the measurement of the size 
of the nanoparticles after interaction with the growing 
microorganisms. In 79% of the observed and measured 
Fig. 4. TEM images of filamentous fungi after the growth with AgNPs in the Bioscreen C: (a, b) Paecilomyces variotii;
(c, d) Penicillium pinophilum; AgNPs, the black structures observed inside the cell and hypha.
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AgNPs particles, the diameter was close to 20 nm, so 
was the size of nanoparticles used in the study. In nearly 
14%, the size was 2–2.5 times greater and in 7% diam-
eter was 4–5 times larger. The distribution of AgNPs 
varied with particle diameter. Large AgNPs prevailed 
inside the cells while small ones dominated outside 
(Table III, Fig. 5).
The higher size of AgNPs inside the cells was prob-
ably due to cytoplasm properties to engender aggre-
gation of AgNPs or protein corona formation. Such 
agglomeration was described by Rahman et al. (2013) 
and Bargheer et al. (2015) as the result of surface prop-
erties of proteins, as well as nanoparticles. The rela-
tively high initial OD value for the samples with AgNPs 
observed in Bioscreen C microcultures (Fig. 2A and B; 
time 0 h) may result from the AgNP protein corona for-
mation with the medium peptides, finally making the 
medium less transparent. However, the size of AgNPs 
found after S. aureus growth in Bioscreen C (with dif-
ferent nanoparticle doses) was not changed.
Many authors have studied the antimicrobial activ-
ity of AgNPs and found some peculiarities. Kaiser 
et al. (2017) described the influence of medium com-
position on nanosilver cytotoxicity, especially after the 
addition of serum and chloride. Also, food components 
influence the level of Ag+ release from the packaging 
material (Song et al. 2011), where Ag+ migration from 
food containers manufactured with silver and nanosil-
21.45 ± 5.9  79.1 37.4 51.6 11 100
54.49 ± 9.1  13.9 93.8  6.25  0 100
94.62 ± 18.16   7.0 85.7 14.3  0 100
Total 100 48.7 42.6  8.7 100
Table III
The size and distribution (inside, outside, and within the cell wall) 
of AgNPs after their interaction with microorganisms.
AgNPs
Size [nm]
Cell distribution according
o the size [%]
[%]
Inside Outside In thecell wall Total
Fig. 5. TEM images of the bacterium and yeasts after the growth in the BioscreenC: (a) Pseudomonas aeruginosa without AgNPs;
(b) P. aeruginosa with AgNPs; (c, d) Candida albicans with AgNPs, the black structures visible inside and outside of cells.
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ver was revealed (Echegoyen and Nerin 2013). Silver 
ions are more toxic than AgNO3 and nanoparticles. 
The minimal toxic dose of silver ions for humans is 
0.014 mg/kg/day and only 1–2% accumulate in the 
body. Wen et al. (2016) reported that AgNPs at con-
centrations below 0.1 mg/l had low but observable 
cytotoxicity toward human buccal epithelial cells. The 
same concentration was the secondary maximum con-
taminant level of silver in drinking water (EPA 2017).
The antimicrobial activity of AgNPs also depends 
on the shape of nanoparticles. Pal et al. (2007) noted 
a stronger biocidal effect for truncated triangular silver 
nanoplates. These authors affirmed that for the safe use of 
AgNPs some questions had to be resolved (Bunds-
chuh et al. 2016; Zarschler et al. 2016). Bundschuh et al. 
(2016) pointed out that long term consequences of the 
uptake by organisms of the engineered nanoparticles 
that are transferred throughout the food chain and may 
affect the microbial, plant, invertebrate, and fish com-
munities, as well as the environment, is only partially 
understood and requires further systematic investiga-
tion. The study performed on nanoparticles used as 
antimicrobial agents against the molds causing deterio-
ration of buildings and construction materials could also 
improve our living conditions. The environment pro-
tection becomes a very important issue for the human 
future and the use of AgNPs as antimicrobial agents 
could be in favor to overcome pollution by chemicals. 
Biocides used as antimicrobial agents are applied at 
rather high concentrations. Koziróg et al. (2016) tested 
seven compounds for their biocidal activity against 
microorganisms isolated from a wooden surface at the 
Auschwitz II-Birkenau Former German Nazi Concen-
tration and Extermination Camp. Three of them were 
active, exhibiting biocidal activity at the concentration 
of 0.02–2% (200–20 000 mg/l). These active compounds 
were the ingredients of eight commercial biocides tested 
by the same researchers on wood pieces contaminated 
with microorganisms by triple spraying of the surface. 
According to the authors some of those biocides inhib-
ited growth at the concentration of 6% (v/v), and oth-
ers only at 30% (v/v). We found that the concentration 
of 9–10.7 mg/l of AgNPs (sized 20 nm) is sufficient to 
exhibit high anti-mold, anti-yeast, and anti-bacterial 
activity in the laboratory tests. The supplementation of 
materials used in the house construction with AgNPs at 
the low concentration (10.7 mg/l = 0.00107%) could be 
a better solution for the environment and human life.
Conclusions
The AgNPs tested inhibited the growth of A. bra- 
siliensis, C. globosum, P. pinophilum, P. variotii, and 
T. virens. Therefore, AgNPs can be used to prevent 
molds invasion on construction materials. The sensi-
tivity to AgNPs depends on the molds species. Total 
inhibition of P. variotii growth was observed at a very 
small concentration of AgNPs (4.28 mg/l).
The TEM images revealed that AgNPs entered into 
the bacterial, yeast, and fungal cells and aggregated in 
larger particles exclusively inside cells of eukaryotic 
microorganisms. Such types of nanosilver aggregation 
have not yet been reported in literature and accumu-
lation of AgNPs in the cell wall of A. brasiliensis cells 
was observed for the first time. Peculiarities of fungal 
interaction with AgNPs presented in this paper could 
be an interesting area of future research.
   ORCID
Tomasz Koźlecki 0000-0002-7890-0936
Michał Piegza 0000-0001-9183-5692
Barbara Żarowska 0000-0002-7149-0647
Acknowledgments
We kindly thank Dr. Jakub Grzesiak from EIT, Wrocław for help 
in the interpretation of TEM images. The research was financed by 
the National Center of Research and Development (NCBR) project 
number No PBS 3/B1/10/2015. The publication was supported by 
Wrocław Centre of Biotechnology, program the Leading National 
Research Centre (KNOW) for years 2014–2018.
Conflict of interest
The authors do not report any financial or personal connections 
with other persons or organizations, which might negatively affect 
the contents of this publication and/or claim authorship rights to 
this publication.
Literature
Abou-Shanab RAI, van Berkum P, Angle JS. Heavy metal resis-
tance and genotypic analysis of metal resistance genes in gram-
positive and gram-negative bacteria present in Ni-rich serpentine 
soil and in the rhizosphere of Alyssum murale. Chemosphere. 2007 
Jun;68(2):360–367.
https://doi.org/10.1016/j.chemosphere.2006.12.051
Akter M, Sikder MT, Rahman MM, Ullah AKMA, Hossain KFB, 
Banik S, Hosokawa T, Saito T, Kurasaki M. A systematic review 
on silver nanoparticles-induced cytotoxicity: physicochemical pro-
perties and perspectives. J Adv Res. 2018 Jan;9:1–16.
https://doi.org/10.1016/j.jare.2017.10.008
Anil Kumar S, Abyaneh MK, Gosavi SW, Kulkarni SK, Pasricha R, 
Ahmad A, Khan MI. Nitrate reductase-mediated synthesis of silver 
nanoparticles from AgNO3. Biotechnol Lett. 2007 Feb 16;29(3): 
439–445. https://doi.org/10.1007/s10529-006-9256-7
AshaRani PV. Hande MP, Valiyaveettil S. Anti-proliferative acti-
vity of silver nanoparticles. BMC Cell Biol. 2009;10:Article 65. 
https://doi.org/10.1186/1471-2121-10-65
Bargheer D, Nielsen J, Gébel G, Heine M, Salmen SC, Stauber R, 
Weller H, Heeren J, Nielsen P. The fate of a designed protein corona 
on nanoparticles in vitro and in vivo. Beilstein J Nanotechnol. 2015 
Jan 06;6:36–46. https://doi.org/10.3762/bjnano.6.5
Bartłomiejczyk T, Lankoff A, Kruszewski M, Szumiel I. Silver 
nanoparticles – allies or adversaries? Ann Agric Environ Med. 2013; 
20(1):48–54.
Żarowska B. et al. 4524
Bundschuh M, Seitz F, Rosenfeldt RR, Schulz R. Effects of nano-
particles in fresh waters: risks, mechanisms and interactions. 
Freshw Biol. 2016 Dec;61(12):2185–2196.
https://doi.org/10.1111/fwb.12701
Chong TM, Yin WF, Mondy S, Grandclément C, Dessaux  Y, 
Chan KG. Heavy-metal resistance of a France vineyard soil bac-
terium, Pseudomonas mendocina strain S5.2, revealed by whole-
genome sequencing. J Bacteriol. 2012 Nov 15;194(22):6366.
https://doi.org/10.1128/JB.01702-12
Dar MA, Ingle A, Rai M. Enhanced antimicrobial activity of silver 
nanoparticles synthesized by Cryphonectria sp. evaluated singly 
and in combination with antibiotics. Nanomedicine. 2013 Jan;9(1): 
105–110. https://doi.org/10.1016/j.nano.2012.04.007
del Pino P, Pelaz B, Zhang Q, Maffre P, Nienhaus GU, Parak WJ. 
Protein corona formation around nanoparticles – from the past to 
the future. Mater Horiz. 2014;1(3):301–313.
https://doi.org/10.1039/C3MH00106G
Durán N, Durán M, de Jesus MB, Seabra AB, Fávaro WJ, Naka-
zato G. Silver nanoparticles: A new view on mechanistic aspects 
on antimicrobial activity. Nanomedicine. 2016 Apr;12(3):789–799. 
https://doi.org/10.1016/j.nano.2015.11.016
Echegoyen Y, Nerín C. Nanoparticle release from nano-silver anti-
microbial food containers. Food Chem Toxicol. 2013 Dec;62:16–22. 
https://doi.org/10.1016/j.fct.2013.08.014
EPA. Secondary drinking water standards: guidance for nuisance 
chemicals [Internet]. Washington, DC (USA): United States Envi-
ron mental Protection Agency; 2017 Mar 8 [cited 2019 May 15]. 
Available from
https://www.epa.gov/dwstandardsregulations/secondary-drinking-
water-standards-guidance-nuisance-chemicals
Flores-López LZ, Espinoza-Gómez H, Somanathan R. Silver 
nano particles: electron transfer, reactive oxygen species, oxidative 
stress, beneficial and toxicological effects. Mini review. J Appl 
Toxicol. 2019 Jan;39(1):16–26. https://doi.org/10.1002/jat.3654
Galván Márquez I, Ghiyasvand M, Massarsky A, Babu M, 
Samanfar B, Omidi K, Moon TW, Smith ML, Golshani A. 
Zinc oxide and silver nanoparticles toxicity in the baker’s yeast, 
Saccharomyces cerevisiae. PLoS One. 2018 Mar 19;13(3):e0193111. 
https://doi.org/10.1371/journal.pone.0193111
Guzman M, Dille J, Godet S. Synthesis and antibacterial activity 
of silver nanoparticles against gram-positive and gram-negative 
bacteria. Nanomedicine. 2012 Jan;8(1):37–45.
https://doi.org/10.1016/j.nano.2011.05.007
Jo YK, Kim BH, Jung G. Antifungal activity of silver ions and 
nanoparticles on phytopathogenic fungi. Plant Dis. 2009 Oct;93(10): 
1037–1043. https://doi.org/10.1094/PDIS-93-10-1037
Kaiser JP, Roesslein M, Diener L, Wichser A, Nowack B, Wick P. 
Cytotoxic effects of nanosilver are highly dependent on the chloride 
concentration and the presence of organic compounds in the cell 
culture media. J Nanobiotechnology. 2017 Dec;15(1):5.
https://doi.org/10.1186/s12951-016-0244-3
Kanawaria SK, Sankhla A, Jatav PK, Yadav RS, Verma KS, Velraj P, 
Kachhwaha S, Kothari SL. Rapid biosynthesis and charac teri- 
zation of silver nanoparticles: an assessment of antibacterial and 
antimycotic activity. Appl Phys, A Mater Sci Process. 2018 Apr; 
124(4): 320. https://doi.org/10.1007/s00339-018-1701-7
Kędziora A, Krzyżewska E, Dudek B, Bugla-Płoskońska G. [The 
participation of outer membranes proteins in the bacterial sen si ti-
vity to nanosilver]. Postepy Hig Med Dosw. 2016;70:610–617.
https://doi.org/10.5604/17322693.1205005
Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, 
Park  YK, Park YH, Hwang CY, et al. Antimicrobial effects of 
silver nanoparticles. Nanomedicine. 2007 Mar;3(1):95–101.
https://doi.org/10.1016/j.nano.2006.12.001
Kim KJ, Sung WS, Suh BK, Moon SK, Choi JS, Kim JG, Lee DG. 
Antifungal activity and mode of action of silver nano-particles on 
Candida albicans. Biometals. 2009 Apr;22(2):235–242.
https://doi.org/10.1007/s10534-008-9159-2
Kobiałka N, Mularczyk M, Kosiorowska K, Pilarska K, Łaba W, 
Piegza M, Robak M. New strains of filamentous fungi isolated 
from construction materials. EJPAU. 2019;22(1):#02.
https://doi.org/10.30825/5.ejpau.169.2019.22.1
Kokura S, Handa O, Takagi T, Ishikawa T, Naito Y, Yoshikawa T. 
Silver nanoparticles as a safe preservative for use in cosmetics. 
Nanomedicine. 2010 Aug;6(4):570–574.
https://doi.org/10.1016/j.nano.2009.12.002
Koziróg A, Rajkowska K, Otlewska A, Piotrowska M, Kunicka-
Styczyńska A, Brycki B, Nowicka-Krawczyk P, Kościelniak M, 
Gutarowska B. Protection of historical wood against microbial 
degradation – selection and application of microbiocides. Int J Mol 
Sci. 2016 Aug 22;17(8):1364.
https://doi.org/10.3390/ijms17081364
Koźlecki T, Teterycz H, Sokołowski A, Polowczyk I, Sawiński W, 
Maliszewska I, Szydło J. Sposób syntezowania nanocząstek srebra. 
PL Patent deposition 2011; No P395979.
Lara HH, Romero-Urbina DG, Pierce C, Lopez-Ribot JL, Arellano- 
Jiménez MJ, Jose-Yacaman M. Effect of silver nanoparticles on 
Candida albicans biofilms: an ultrastructural study. J Nanobio tech-
nology. 2015 Dec;13(1):91–102.
 https://doi.org/10.1186/s12951-015-0147-8
Latgé JP, Mouyna I, Tekaia F, Beauvais A, Debeaupuis JP, 
Nierman W. Specific molecular features in the organization and 
bio synthesis of the cell wall of Aspergillus fumigatus. Med Mycol. 
2005 Jan;43(s1) Suppl 1:15–22.
https://doi.org/10.1080/13693780400029155
Lee S, Jun BH. Silver Nanoparticles: synthesis and application for 
nanomedicine. Int J Mol Sci. 2019 Feb 17;20(4):865.
https://doi.org/10.3390/ijms20040865
Li WR, Xie XB, Shi QS, Zeng HY, OU-Yang YS, Chen YB. Anti - 
bacterial activity and mechanism of silver nanoparticles on Esche-
richia coli. Appl Microbiol Biotechnol. 2010 Jan;85(4):1115–1122.
https://doi.org/10.1007/s00253-009-2159-5
Li XZ, Nikaido H, Williams KE. Silver-resistant mutants of Esche-
richia coli display active efflux of Ag+ and are deficient in porins. 
J Bacteriol. 1997 Oct;179(19):6127–6132.
https://doi.org/10.1128/jb.179.19.6127-6132.1997
Łukaszuk CR, Krajewska-Kułak E, Kułak W. Effects of fungal air 
pollution on human health. Prog Health Sci. 2011;1(2):156–164.
Martinez-Gutierrez F, Olive PL, Banuelos A, Orrantia E, 
Nino  N, Sanchez EM, Ruiz F, Bach H, Av-Gay Y. Synthesis, 
cha rac terization, and evaluation of antimicrobial and cytotoxic 
effect of silver and titanium nanoparticles. Nanomedicine. 2010 
Oct;6(5):681–688.
https://doi.org/10.1016/j.nano.2010.02.001
McShan D, Ray PC, Yu H. Molecular toxicity mechanism of nano-
silver. Yao Wu Shi Pin Fen Xi. 2014 Mar;22(1):116–127.
https://doi.org/10.1016/j.jfda.2014.01.010
Metak AM, Ajaal TT. Investigation on polymer based nano-silver 
as packaging materials. Int Schol Scien Res Inn. 2013;7(12):772–778.
Milić M, Leitinger G, Pavičić I, Zebić Avdičević M, Dobrović S, 
Goessler W, Vinković Vrček I. Cellular uptake and toxicity effects 
of silver nanoparticles in mammalian kidney cells. J Appl Toxicol. 
2015 Jun;35(6):581–592.
https://doi.org/10.1002/jat.3081
Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, 
Ramírez JT, Yacaman MJ. The bactericidal effect of silver nano-
par ticles. Nanotechnology. 2005 Oct 01;16(10):2346–2353.
https://doi.org/10.1088/0957-4484/16/10/059
New look on antifungal activity of nanoparticles4 525
Nowicka-Krawczyk P, Żelazna-Wieczorek J, Koźlecki T. Silver 
nano particles as a control agent against facades coated by aerial 
algae – A model study of Apatococcus lobatus (green algae). PLoS 
One. 2017 Aug 14;12(8):e0183276.
https://doi.org/10.1371/journal.pone.0183276
Pal S, Tak YK, Song JM. Does the antibacterial activity of silver 
nanoparticles depend on the shape of the nanoparticle? A study 
of the Gram-negative bacterium Escherichia coli. Appl Environ 
Microbiol. 2007 Mar 15;73(6):1712–1720.
https://doi.org/10.1128/AEM.02218-06
Park MVDZ, Neigh AM, Vermeulen JP, de la Fonteyne LJJ, 
Verharen HW, Briedé JJ, van Loveren H, de Jong WH. The effect 
of particle size on the cytotoxicity, inflammation, developmental 
toxicity and genotoxicity of silver nanoparticles. Biomaterials. 2011 
Dec;32(36):9810–9817.
https://doi.org/10.1016/j.biomaterials.2011.08.085
PN-EN ISO 846. Polska norma. Tworzywa sztuczne. Ocena dzia- 
łania mikroorganizmów [Plastics-Evaluation of the action of the 
microorganisms, actualization 2019:05]. 2002 Dec.
Pulit J, Banach M, Szczygłowska R, Bryk M. Nanosilver against 
fungi. Silver nanoparticles as an effective biocidal factor. Acta 
Biochim Pol. 2013;60(4):795–798.
Radhakrishnan VS, Reddy Mudiam MK, Kumar M, Dwivedi SP, 
Singh SP, Prasad T. Silver nanoparticles induced alterations in 
multiple cellular targets, which are critical for drug susceptibilities 
and pathogenicity in fungal pathogen (Candida albicans). Int J Nano- 
 medicine. 2018 May;13:2647–2663.
https://doi.org/10.2147/IJN.S150648
Rahman M, Laurent S, Tawil N, Yahia L, Mahmoudi M. Nano-
particle and protein corona. In: Protein-nanoparticles interactions. 
The Bio-Nano Interface. Springer Series in Biophysics. Berlin, 
Heidel berg (Germany): Springer; 2013;15. p. 21–44.
https://doi.org/10.1007/978-3-642-37555-2_2
Rai M, Ingle AP, Gaikwad S, Gupta I, Gade A, Silvério da Silva S. 
Nanotechnology based anti-infectives to fight microbial intrusions. 
J Appl Microbiol. 2016 Mar;120(3):527–542.
https://doi.org/10.1111/jam.13010
Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation 
of antimicrobials. Biotechnol Adv. 2009 Jan;27(1):76–83.
https://doi.org/10.1016/j.biotechadv.2008.09.002
Riaz Ahmed KB, Nagy AM, Brown RP, Zhang Q, Malghan SG, 
Goering PL. Silver nanoparticles: significance of physicochemical 
properties and assay interference on the interpretation of in vitro 
cytotoxicity studies. Toxicol In Vitro. 2017 Feb;38:179–192.
https://doi.org/10.1016/j.tiv.2016.10.012
Robak M. Yarrowia lipolytica specific growth rate on acetate 
medium supplemented with glucose, glycerol or ethanol. Acta Sci 
Polon Biotechnologia. 2007;6(1):23–31.
Roe D, Karandikar B, Bonn-Savage N, Gibbins B, Roullet JB. 
Antimicrobial surface functionalization of plastic catheters by silver 
nanoparticles. J Antimicrob Chemother. 2008 Feb 04;61(4):869–876. 
https://doi.org/10.1093/jac/dkn034
Salvadori MR, Nascimento CAO, Corrêa B. Nickel oxide nano-
par ticles film produced by dead biomass of filamentous fungus. Sci 
Rep. 2015 May;4(1):6404.
https://doi.org/10.1038/srep06404
Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S. Synthesis 
and effect of silver nanoparticles on the antibacterial activity of 
different antibiotics against Staphylococcus aureus and Escherichia 
coli. Nanomedicine. 2007 Jun;3(2):168–171.
https://doi.org/10.1016/j.nano.2007.02.001
Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial 
agent: a case study on E. coli as a model for Gram-negative bacteria. 
J Colloid Interface Sci. 2004 Jul;275(1):177–182.
https://doi.org/10.1016/j.jcis.2004.02.012
Song H, Li B, Lin QB, Wu HJ, Chen Y. Migration of silver from 
nanosilver–polyethylene composite packaging into food simulants. 
Food Additives & Contaminants: Part A. 2011 Jul 08;28(12):1–5.
https://doi.org/10.1080/19440049.2011.603705
Tran QH, Nguyen VQ, Le A-T. Silver nanoparticles: synthesis, 
properties, toxicology, applications and perspectives. Adv. Nat. Sci. 
Nanosci. Nanotechnol. 2013;4:033001, 20pp,
https://doi.org/10.1088/2043-6262/4/3/033001
Wen R, Hu L, Qu G, Zhou Q, Jiang G. Exposure, tissue biodistri-
bution, and biotransformation of nanosilver. NanoImpact. 2016 
Apr;2:18–28. https://doi.org/10.1016/j.impact.2016.06.001
Xu Y, Gao C, Li X, He Y, Zhou L, Pang G, Sun S. In vitro anti-
fungal activity of silver nanoparticles against ocular pathogenic fila-
mentous fungi. J Ocul Pharmacol Ther. 2013 Mar;29(2):270–274. 
https://doi.org/10.1089/jop.2012.0155
Yoon KY, Hoon Byeon J, Park JH, Hwang J. Susceptibility con-
stants of Escherichia coli and Bacillus subtilis to silver and copper 
nanoparticles. Sci Total Environ. 2007 Feb;373(2-3):572–575.
https://doi.org/10.1016/j.scitotenv.2006.11.007
Zarschler K, Rocks L, Licciardello N, Boselli L, Polo E, Garcia KP, 
De Cola L, Stephan H, Dawson KA. Ultrasmall inorganic nano-
particles: state-of-the-art and perspectives for biomedical appli ca-
tions. Nanomedicine. 2016 Aug;12(6):1663–1701.
https://doi.org/10.1016/j.nano.2016.02.019
Zhang X-F, Liu Z-G, Shen W. Gurunathan S. Silver nanoparticles: 
synthesis, characterization, properties, applications, and thera peu-
tic approaches. Int J Mol Sci. 2016a;17(9):1534.
https://doi.org/10.3390/ijms17091534
Zhang X-F, Shen W, Gurunathan S. Silver nanoparticle-mediated 
cellular responses in various cell lines: an in vitro model. Int J Med 
Sci. 2016b;17:1603. https://doi.org/10.3390/ijmps17101603
Zou J, Hannula M, Misra S, Feng H, Labrador R, Aula AS, 
Hyttinen J, Pyykkö I. Micro CT visualization of silver nanoparticles 
in the middle and inner ear of rat and transportation pathway after 
transtympanic injection. J Nanobiotechnology. 2015;13(1):5.
https://doi.org/10.1186/s12951-015-0065-9
Żarowska B, Piegza M, Jaros-Koźlecka K, Koźlecki T, Robak M. 
Antimicrobial activity of silver nanoparticles. Conference material: 
Wrocław (Poland): BRIA; 2015;55.
